@entity11545 ( XXXX ) once daily outcome and satisfaction survey (RODOS) in mild to moderate @entity195 : a study in a real life population.

@entity1 @entity11545 @entity11544 @entity195 @entity8124
AIM: To record in real life the appreciation of elderly @entity1 , their caregivers and physicians of a once daily formulation of prolonged release of @entity11545 in the treatment of mild to moderate @entity195 . METHODS: A prospective, multicenter, observational study was conducted in 128 elderly @entity1 , treated for 6 months with @entity11545 , @entity8124 or @entity11544 . RESULTS: Of the @entity1 treated with @entity11545 , 82 of the 97 (84.5%) were continuing their treatment after 6 months. These @entity1 reported their condition as improved in 49%, unchanged in 47% and worsened in 4%. Caregivers rated global evaluation as 37% better, 41% unchanged and 22% worse. Physicians rated global clinical impression of change as 46% better, 34% unchanged and 20% worse. Measurements of cognition and behavior remained stable. The appreciation of physicians and caregivers corresponded well (P<0.001). The incidence of serious side-effects possibly related to @entity11545 was 9.3%, which was not different from that in @entity1 treated with other cholinesterase inhibitors. CONCLUSION: In a real life setting, @entity11545 once daily is safe and is favorably appreciated by @entity1 , their caregivers and physicians.
